512 related articles for article (PubMed ID: 15352905)
1. Review article: treatment of perianal fistulizing Crohn's disease.
Rutgeerts P
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():106-10. PubMed ID: 15352905
[TBL] [Abstract][Full Text] [Related]
2. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
3. Review article: The medical treatment of Crohn's perianal fistulas.
Schwartz DA; Herdman CR
Aliment Pharmacol Ther; 2004 May; 19(9):953-67. PubMed ID: 15113362
[TBL] [Abstract][Full Text] [Related]
4. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
5. Management of perianal Crohn's disease.
Rutgeerts P
Can J Gastroenterol; 2000 Sep; 14 Suppl C():7C-12C. PubMed ID: 11023554
[TBL] [Abstract][Full Text] [Related]
6. Review article: Medical therapy for fistulizing Crohn's disease.
Bressler B; Sands BE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab.
Bouguen G; Trouilloud I; Siproudhis L; Oussalah A; Bigard MA; Bretagne JF; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2009 Oct; 30(7):749-56. PubMed ID: 19583709
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
[TBL] [Abstract][Full Text] [Related]
9. Treatment of fistulizing Crohn's disease.
Judge TA; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):421-54, xi-xii. PubMed ID: 15177547
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P
Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051
[TBL] [Abstract][Full Text] [Related]
11. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
Gao Q; Hogezand RA; Lamers CB; Verspaget HW
Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
[TBL] [Abstract][Full Text] [Related]
12. Perianal fistulizing Crohn's disease: a call to action.
Kamm MA; Ng SC
Clin Gastroenterol Hepatol; 2008 Jan; 6(1):7-10. PubMed ID: 18063415
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease.
Cat H; Sophani I; Lemann M; Modiglani R; Solue JC
Turk J Gastroenterol; 2003 Jun; 14(2):121-7. PubMed ID: 14614639
[TBL] [Abstract][Full Text] [Related]
14. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
[TBL] [Abstract][Full Text] [Related]
15. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging.
Karmiris K; Bielen D; Vanbeckevoort D; Vermeire S; Coremans G; Rutgeerts P; Van Assche G
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):130-6. PubMed ID: 21056696
[TBL] [Abstract][Full Text] [Related]
16. Local injection of Infliximab for the treatment of perianal Crohn's disease.
Poggioli G; Laureti S; Pierangeli F; Rizzello F; Ugolini F; Gionchetti P; Campieri M
Dis Colon Rectum; 2005 Apr; 48(4):768-74. PubMed ID: 15768185
[TBL] [Abstract][Full Text] [Related]
17. Fistulizing Crohn's disease.
Felley C; Mottet C; Juillerat P; Pittet V; Froehlich F; Vader JP; Michetti P; Gonvers JJ
Digestion; 2007; 76(2):109-12. PubMed ID: 18239401
[TBL] [Abstract][Full Text] [Related]
18. The patient with persistent perianal fistulae.
Koutroubakis IE
Best Pract Res Clin Gastroenterol; 2007; 21(3):503-18. PubMed ID: 17544114
[TBL] [Abstract][Full Text] [Related]
19. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG
Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797
[TBL] [Abstract][Full Text] [Related]
20. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]